Daysha Robinson

Contributions

Understanding the Mechanism of Action of Rituximab in Patients With NMOSD

Rituximab can help patients with NMOSD, but its mechanism is not fully understood. This article explores one possible hypothesis. Neuromyelitis optica spectrum disorders (NMOSD) are autoimmune conditions caused by immunoglobulin G (IgG) autoantibodies directed against the water channel aquaporin-4. Among patients with NMOSD, clinical relapses tend to lead to disability. Relapses can be prevented by...

Vision Loss Variations Among Patients With MS, NMOSD, and MOGAD

Vision loss occurs in patients with MS, NMOSD, and MOGAD, and this study analyzes the different ways and amounts that this occurs. Some patients with neuromyelitis optica spectrum disorders (NMOSD) exhibit optic neuritis (ON), and this can result in more severe vision loss when compared to multiple sclerosis (MS) and myelin oligodendrocyte glycoprotein antibody-associated disease...

Adjusting with Vitiligo - James McLeod

James Mcleod is a patient advocate who has vitiligo. In this interview, he tells us what it’s like to adjust to managing vitiligo, and he shares his advice for other people living with the condition. Describe how you have to adjust to managing Vitiligo. James Mcleod: I knew I had a visual difference and there...

What It's Like Having Vitiligo - James McLeod

James Mcleod is a Vitiligo patient advocate and someone who has been living with vitiligo since he was a child. In this interview, we talk about what it was like for him growing up with vitiligo, how he’s learned to cope over the years, and what he’s doing now to help others who are dealing...

Advice for Vitiligo Patients - James McLeod

The first step in any successful treatment plan is acceptance. As a patient himself, James McLeod knows this all too well. He’s lived with vitiligo since he was a kid and has been through the ups and downs. In this interview, he gives his advice to patients who just got diagnosed with vitiligo. What advice...

The Demographics of Treatment Delay in Patients with Vitiligo

Treatment delays can cause complications later on for patients with vitiligo. This study analyzed demographic disparities related to increased treatment delays among those exhibiting vitiligo symptoms. Delayed treatment of vitiligo is known to decrease the chance of successful disease stabilization and repigmentation due to how much more effective therapies are during the early stages of...

A Population-Based Study of Vitiligo Prevalence Among US Adults

This article provides a population-based study about self-reported vitiligo prevalence among adults in the United States, which is especially valuable as a way to understand the rates of undiagnosed vitiligo. The prevalence of vitiligo in the United States population, as it relates to various demographic subgroups, can be a good way of understanding public health-related...

Structural Network Disruptions in Patients with MS and NMOSD

Patients with multiple sclerosis showed more advanced white matter alteration compared to those with neuromyelitis optica spectrum disorder, although both exhibited altered network topologies. Along with neuromyelitis optica spectrum disorder (NMOSD), multiple sclerosis (MS) is one of the major chronic inflammatory demyelinating disorders that can affect the central nervous system. This study, published in the...

Functional Connectivity and Cognitive Impairment in Patients with NMOSD

This analysis of patients with NMOSD provides data about how functional connectivity in specific cognitive networks impacts cognitive impairment symptoms. Neuromyelitis optica spectrum disorder (NMOSD) can manifest a variety of symptoms, some being more uncommon than others. Cognitive impairment is one of the common symptoms among patients with this disorder, but the mechanism by which...
<< >>

Categories

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.